178 related articles for article (PubMed ID: 28431915)
1. Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates.
Sharifzadeh A; Khosravi AR; Shokri H; Tari PS
Microb Pathog; 2017 Jun; 107():390-396. PubMed ID: 28431915
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Drago M; Scaltrito MM; Morace G;
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
4. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
7. Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
Sharifzadeh A; Khosravi AR; Shokri H; Shirzadi H
J Mycol Med; 2018 Jun; 28(2):294-299. PubMed ID: 29661606
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
9. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
11. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
12. β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin.
Franiczek R; Gleńsk M; Krzyżanowska B; Włodarczyk M
Med Mycol; 2015 Nov; 53(8):845-51. PubMed ID: 26092104
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis.
De-la-Torre J; Ortiz-Samperio ME; Marcos-Arias C; Marichalar-Mendia X; Eraso E; Echebarria-Goicouria MÁ; Aguirre-Urizar JM; Quindós G
Mycopathologia; 2017 Jun; 182(5-6):471-485. PubMed ID: 28124220
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.
Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS
Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
